Related references
Note: Only part of the references are listed.Persisting cancer mortality gap between western and eastern Europe
Claudia Santucci et al.
EUROPEAN JOURNAL OF CANCER (2022)
Lost productivity due to head and neck cancer mortality in Hungary, Poland, and Romania
Goran Bencina et al.
JOURNAL OF CANCER POLICY (2022)
Correlation between work productivity loss and EORTC QLQ-C30 and-BR23 domains from the MONALEESA-7 trial of premenopausal women with HR+/HER2-advanced breast cancer
Debu Tripathy et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2022)
De-escalation of Systemic Therapy for Early-Stage, Node-Negative Her2+and Triple-Negative Breast Cancer
Lorena Gonzalez et al.
CURRENT BREAST CANCER REPORTS (2021)
The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers
Tadeusz Dyba et al.
EUROPEAN JOURNAL OF CANCER (2021)
Triple Negative Breast Cancer: A Review of Present and Future Diagnostic Modalities
Sylvia Annabel Dass et al.
MEDICINA-LITHUANIA (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Direct Medical Costs of Advanced Breast Cancer Treatment: A Real-World Study in the Southeast of The Netherlands
Paul Peter Schneider et al.
VALUE IN HEALTH (2021)
European trends in breast cancer mortality, 1980-2017 and predictions to 2025
Cezary Wojtyla et al.
EUROPEAN JOURNAL OF CANCER (2021)
Breast Cancer Treatments: Updates and New Challenges
Anna Burguin et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
The cost of cancer in Europe 2018
Thomas Hofmarcher et al.
EUROPEAN JOURNAL OF CANCER (2020)
Productivity costs associated with metastatic breast cancer in younger, midlife, and older women
Justin G. Trogdon et al.
CANCER (2020)
Do we still need breast cancer screening in the era of targeted therapies and precision medicine?
Rubina Manuela Trimboli et al.
INSIGHTS INTO IMAGING (2020)
Recent Advances in the Treatment of Breast Cancer
Christy W. S. Tong et al.
FRONTIERS IN ONCOLOGY (2018)
Triple-negative breast cancer: is there a treatment on the horizon?
Hui Yao et al.
ONCOTARGET (2017)
Women With Breast Cancer Who Work For Accommodating Employers More Likely To Retain Jobs After Treatment
Victoria Blinder et al.
HEALTH AFFAIRS (2017)
Productivity losses and public finance burden attributable to breast cancer in Poland, 2010-2014
Blazej Lyszczarz et al.
BMC CANCER (2017)
Awareness and current knowledge of breast cancer
Muhammad Akram et al.
BIOLOGICAL RESEARCH (2017)
Cancer Control in Central and Eastern Europe
Carlo La Vecchia et al.
ONCOLOGIST (2016)
International Variation in Female Breast Cancer Incidence and Mortality Rates
Carol E. DeSantis et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2015)
Measuring the societal burden of cancer: The cost of lost productivity due to premature cancer-related mortality in Europe
Paul Hanly et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Economic burden of cancer across the European Union: a population-based cost analysis
Ramon Luengo-Fernandez et al.
LANCET ONCOLOGY (2013)
Indirect costs associated with metastatic breast cancer
Yin Wan et al.
JOURNAL OF MEDICAL ECONOMICS (2013)
Cancer epidemiology in Central and South Eastern European countries
Eduard Vrdoljak et al.
CROATIAN MEDICAL JOURNAL (2011)
Male Breast Cancer: A Population-Based Comparison With Female Breast Cancer
William F. Anderson et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Employment-contingent health insurance, illness, and labor supply of women: evidence from married women with breast cancer
Cathy J. Bradley et al.
HEALTH ECONOMICS (2007)
Work absence after breast cancer diagnosis:: a population-based study
M Drolet et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2005)
Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality
RG Blanks et al.
BRITISH MEDICAL JOURNAL (2000)